Epigenetic regulation in cardiovascular disease: mechanisms and advances in clinical trials
Y Shi, H Zhang, S Huang, L Yin, F Wang… - … and Targeted Therapy, 2022 - nature.com
Epigenetics is closely related to cardiovascular diseases. Genome-wide linkage and
association analyses and candidate gene approaches illustrate the multigenic complexity of …
association analyses and candidate gene approaches illustrate the multigenic complexity of …
Vascular smooth muscle cells in atherosclerosis
GL Basatemur, HF Jørgensen, MCH Clarke… - Nature reviews …, 2019 - nature.com
Vascular smooth muscle cells (VSMCs) are a major cell type present at all stages of an
atherosclerotic plaque. According to the 'response to injury'and 'vulnerable …
atherosclerotic plaque. According to the 'response to injury'and 'vulnerable …
Circular RNA CircMAP3K5 acts as a MicroRNA-22-3p sponge to promote resolution of intimal hyperplasia via TET2-mediated smooth muscle cell differentiation
Z Zeng, L Xia, S Fan, J Zheng, J Qin, X Fan, Y Liu… - Circulation, 2021 - Am Heart Assoc
Background: Aberrant expression of circular RNA contributes to human diseases. Circular
RNAs regulate gene expression by sequestering specific microRNAs. In this study, we …
RNAs regulate gene expression by sequestering specific microRNAs. In this study, we …
An update on the phenotypic switching of vascular smooth muscle cells in the pathogenesis of atherosclerosis
F Zhang, X Guo, Y Xia, L Mao - Cellular and Molecular Life Sciences, 2022 - Springer
Vascular smooth muscle cells (VSMCs) are involved in phenotypic switching in
atherosclerosis. This switching is characterized by VSMC dedifferentiation, migration, and …
atherosclerosis. This switching is characterized by VSMC dedifferentiation, migration, and …
Vascular smooth muscle cells in intimal hyperplasia, an update
S Déglise, C Bechelli, F Allagnat - Frontiers in physiology, 2023 - frontiersin.org
Arterial occlusive disease is the leading cause of death in Western countries. Core
contemporary therapies for this disease include angioplasties, stents, endarterectomies and …
contemporary therapies for this disease include angioplasties, stents, endarterectomies and …
[HTML][HTML] Targeting smooth muscle cell phenotypic switching in vascular disease
Objective The phenotypic plasticity of vascular smooth muscle cells (VSMCs) is central to
vessel growth and remodeling, but also contributes to cardiovascular pathologies. New …
vessel growth and remodeling, but also contributes to cardiovascular pathologies. New …
miR-128-3p is a novel regulator of vascular smooth muscle cell phenotypic switch and vascular diseases
Rationale: MicroRNAs (miRNAs, miRs) are small noncoding RNAs that modulate gene
expression by negatively regulating translation of target genes. Although the role of several …
expression by negatively regulating translation of target genes. Although the role of several …
Epigenetic-sensitive pathways in personalized therapy of major cardiovascular diseases
The complex pathobiology underlying cardiovascular diseases (CVDs) has yet to be
explained. Aberrant epigenetic changes may result from alterations in enzymatic activities …
explained. Aberrant epigenetic changes may result from alterations in enzymatic activities …
Targeting epigenetics and non-coding RNAs in atherosclerosis: from mechanisms to therapeutics
Atherosclerosis, the principal cause of cardiovascular death worldwide, is a pathological
disease characterized by fibro-proliferation, chronic inflammation, lipid accumulation, and …
disease characterized by fibro-proliferation, chronic inflammation, lipid accumulation, and …
DNA methyltransferase 3B deficiency unveils a new pathological mechanism of pulmonary hypertension
DNA methylation plays critical roles in vascular pathology of pulmonary hypertension (PH).
The underlying mechanism, however, remains undetermined. Here, we demonstrate that …
The underlying mechanism, however, remains undetermined. Here, we demonstrate that …